Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

682 evidences · page 24 / 28

43,6 %Among male patients with sickle cell disease in Ibadan, Nigeria, who experienced priapism, sleeplessness was reported by 43.6%.

Nigeriadrépanocytosepublié 2020West African journal of medicinePubMeddocument de 9 observations

0,435 secondsThe median QTc interval was 0.435 seconds (interquartile range: 0.417–0.440 seconds) during steady-state in children with sickle cell anemia.

Nigeriadrépanocytosepublié 2021HemoglobinPubMeddocument de 5 observations

2,5 %Among 3622 enrolled sickle cell disease patients in Nigeria, the frequency of Hb SC was 2.5%.

Nigeriadrépanocytose · Hb SCpublié 2020Blood cells, molecules & diseaseseurope_pmcdocument de 16 observations

55 %About 165 out of 300 respondents (55.0%) had a positive attitude towards sickle cell disease and premarital screening.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 7 observations

13 yearsThe mean age at onset of breast development (Tanner stage B2) was 13 years in girls with sickle cell anaemia.

Nigeriadrépanocytosepublié 2023West African journal of medicinePubMeddocument de 7 observations

1,45 %About 1.45% of the 138 newly diagnosed sickle cell disease patients had heterozygous sickle-hemoglobin C (SC) variant.

Nigeriadrépanocytoseobservé 2013 to 2014publié 2022The Pan African medical journalPubMeddocument de 9 observations

84,8 %173 (84.8%) of the participants had a fewer need for blood transfusion while using hydroxyurea.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 10 observations

2,3 x10¹²/LRed blood cell count in crisis state subjects was 2.3 ± 0.7.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 14 observations

0,63 %The prevalence of sickle cell disease among adults was 0.63%.

Nigeriadrépanocytoseobservé 2013 to 2014publié 2022The Pan African medical journalPubMeddocument de 9 observations

There was no significant difference in the spot urine NGAL and urine NCR between the 2 groups, though both were higher in the HbS group compared to the HbA group.

Nigeriadrépanocytosepublié 2021Medical principles and practice : international journal of the Kuwait University, Health SPubMeddocument de 3 observations

9,8 %The prevalence of right ventricular diastolic dysfunction among children with sickle cell anaemia was 9.8%.

Nigeriadrépanocytose · right ventricular diastolic dysfunctionpublié 2020BMC pediatricsPubMeddocument de 8 observations

19 monthsThe average age at diagnosis of sickle cell disease was 19 months in Nigeria.

Nigeriadrépanocytosepublié 2025EJHaemeurope_pmcdocument de 7 observations

Patients with relative systemic hypertension and sickle cell anaemia had higher packed cell volumes, smaller right atria area, lower tricuspid regurgitant velocities, lower incidence of early satiety, longer QTc, and higher frequency of a history of vaso-occlusive crises compared to those without relative systemic hypertension.

Nigeriadrépanocytose · relative systemic hypertensionpublié 2020Indian heart journalPubMeddocument de 3 observations

316 patientsA cohort of 316 children aged 1–18 years with sickle cell anaemia was evaluated.

Nigeriadrépanocytosepublié 2021Journal of pediatric endocrinology & metabolism : JPEMPubMeddocument de 6 observations

0,6 %Isoelectric focusing (IEF) tests identified 3 (0.6%) HbAC phenotypes among 511 newborns.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 23 observations

Nigeria bears the highest global burden of sickle cell disease.

Nigeriadrépanocytosepublié 2025BMC public healthPubMeddocument de 5 observations

46,7 %46.7% of respondents expressed willingness to 'take the risk and hope for the best' regarding sickle cell disease birth risk.

Nigeriadrépanocytosepublié 2025BMC public healthPubMeddocument de 6 observations

36,5 %Among 85 sickle cell disease patients in a Nigerian hospital, 36.5% had more than three painful crises in a year.

NigeriadrépanocytosePubMeddocument de 10 observations

84,7 %The prevalence of growth failure and short stature among children aged 1–18 years with sickle cell anaemia was 84.7%.

Nigeriadrépanocytosepublié 2021Journal of pediatric endocrinology & metabolism : JPEMPubMeddocument de 6 observations

25,38 yearsThe mean age of the participants was 25.38 years among clinically stable Nigerian adults with sickle cell disease.

Nigeriadrépanocytosepublié 2020Nigerian journal of clinical practicePubMeddocument de 8 observations

100 %For 14 newborns with sickle cell disease who accepted diagnosis and were enrolled into the SCD program, HemoTypeSC had 100% sensitivity when compared with alkaline cellulose acetate hemoglobin electrophoresis (ACAE) repeated at age ≥6 months.

Nigeriadrépanocytosepublié 2024Hemoglobineurope_pmcdocument de 10 observations

The Ibadan patients did not receive hydroxyurea (HU) therapy as frequently as the Chicago patients.

Nigeriadrépanocytosepublié 2014Hemoglobineurope_pmcdocument de 5 observations

1 %Prevalence of sickle cell disease across African countries ranges between 1% and 3%.

Nigeriadrépanocytosepublié 2025Communications medicineeurope_pmcdocument de 4 observations

The weight, height, BMI, systolic blood pressure, plasma urea, plasma creatinine, and spot urine creatinine of the HbS genotype children were significantly lower compared to that of the HbA genotype children.

Nigeriadrépanocytosepublié 2021Medical principles and practice : international journal of the Kuwait University, Health SPubMeddocument de 3 observations

38,4 cm²Ulcers in patients with sickle cell anaemia ranged from 0.5 cm² to 416 cm², with a median of 38.4 cm².

Nigeriadrépanocytoseobservé 2015publié 2020African journal of laboratory medicineeurope_pmcdocument de 3 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.